25 XP   0   0   10

Control Bionics Ltd
Buy, Hold or Sell?

Let's analyse Control Bionics Ltd together

PenkeI guess you are interested in Control Bionics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Control Bionics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Control Bionics Ltd

I send you an email if I find something interesting about Control Bionics Ltd.

Quick analysis of Control Bionics Ltd (30 sec.)










What can you expect buying and holding a share of Control Bionics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
A$0.04
Expected worth in 1 year
A$-0.07
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
A$-0.11
Return On Investment
-260.3%

For what price can you sell your share?

Current Price per Share
A$0.04
Expected price per share
A$0.041 - A$0.05
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Control Bionics Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.04

Intrinsic Value Per Share

A$-0.12 - A$-0.07

Total Value Per Share

A$-0.08 - A$-0.03

2. Growth of Control Bionics Ltd (5 min.)




Is Control Bionics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$4.6m$7.7m-$3.1m-66.8%

How much money is Control Bionics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.6m-$3.9m$313.2k8.5%
Net Profit Margin-103.6%-139.5%--

How much money comes from the company's main activities?

3. Financial Health of Control Bionics Ltd (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#275 / 345

Most Revenue
#230 / 345

Most Profit
#210 / 345

Most Efficient
#250 / 345
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Control Bionics Ltd? (5 min.)

Welcome investor! Control Bionics Ltd's management wants to use your money to grow the business. In return you get a share of Control Bionics Ltd.

What can you expect buying and holding a share of Control Bionics Ltd?

First you should know what it really means to hold a share of Control Bionics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Control Bionics Ltd is A$0.043. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Control Bionics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Control Bionics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.04. Based on the TTM, the Book Value Change Per Share is A$-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Control Bionics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-50.2%-0.02-50.2%-0.02-54.4%-0.01-32.5%0.0243.5%
Usd Book Value Change Per Share-0.02-42.6%-0.02-42.6%-0.02-46.7%0.001.9%0.008.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.0115.3%
Usd Total Gains Per Share-0.02-42.6%-0.02-42.6%-0.02-46.7%0.001.9%0.0123.2%
Usd Price Per Share0.10-0.10-0.25-0.18-0.11-
Price to Earnings Ratio-4.51--4.51--10.72--11.20--7.00-
Price-to-Total Gains Ratio-5.32--5.32--12.49--22.21--22.21-
Price to Book Ratio3.55-3.55-5.49-3.49-2.18-
Price-to-Total Gains Ratio-5.32--5.32--12.49--22.21--22.21-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.028122
Number of shares35559
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (35559 shares)-650.7528.81
Gains per Year (35559 shares)-2,602.98115.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2603-26130115105
20-5206-52160231220
30-7809-78190346335
40-10412-104220461450
50-13015-130250576565
60-15618-156280692680
70-18221-182310807795
80-20824-208340922910
90-23427-23437010371025
100-26030-26040011531140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.06.00.025.0%2.06.00.025.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.05.00.037.5%3.05.00.037.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%2.00.06.025.0%2.00.06.025.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%3.05.00.037.5%3.05.00.037.5%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Control Bionics Ltd

About Control Bionics Ltd

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; NeuroNode Duo, a wireless sensor; and Eye gaze Duo that allows the user to control a computer mouse with their eyes. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.

Fundamental data was last updated by Penke on 2024-02-15 04:39:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Control Bionics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Control Bionics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Control Bionics Ltd to the Medical Devices industry mean.
  • A Net Profit Margin of -103.6% means that $-1.04 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Control Bionics Ltd:

  • The MRQ is -103.6%. The company is making a huge loss. -2
  • The TTM is -103.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-103.6%TTM-103.6%0.0%
TTM-103.6%YOY-139.5%+35.9%
TTM-103.6%5Y-118.9%+15.3%
5Y-118.9%10Y-85.0%-33.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-103.6%-11.2%-92.4%
TTM-103.6%-16.7%-86.9%
YOY-139.5%-13.6%-125.9%
5Y-118.9%-19.1%-99.8%
10Y-85.0%-22.6%-62.4%
1.1.2. Return on Assets

Shows how efficient Control Bionics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Control Bionics Ltd to the Medical Devices industry mean.
  • -64.8% Return on Assets means that Control Bionics Ltd generated $-0.65 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Control Bionics Ltd:

  • The MRQ is -64.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -64.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-64.8%TTM-64.8%0.0%
TTM-64.8%YOY-45.5%-19.3%
TTM-64.8%5Y-34.7%-30.0%
5Y-34.7%10Y-22.7%-12.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-64.8%-3.5%-61.3%
TTM-64.8%-4.4%-60.4%
YOY-45.5%-3.6%-41.9%
5Y-34.7%-3.9%-30.8%
10Y-22.7%-4.3%-18.4%
1.1.3. Return on Equity

Shows how efficient Control Bionics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Control Bionics Ltd to the Medical Devices industry mean.
  • -78.8% Return on Equity means Control Bionics Ltd generated $-0.79 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Control Bionics Ltd:

  • The MRQ is -78.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -78.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-78.8%TTM-78.8%0.0%
TTM-78.8%YOY-51.2%-27.5%
TTM-78.8%5Y-39.5%-39.3%
5Y-39.5%10Y-23.1%-16.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-78.8%-3.8%-75.0%
TTM-78.8%-5.0%-73.8%
YOY-51.2%-4.5%-46.7%
5Y-39.5%-5.5%-34.0%
10Y-23.1%-6.2%-16.9%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Control Bionics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Control Bionics Ltd is operating .

  • Measures how much profit Control Bionics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Control Bionics Ltd to the Medical Devices industry mean.
  • An Operating Margin of -103.4% means the company generated $-1.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Control Bionics Ltd:

  • The MRQ is -103.4%. The company is operating very inefficient. -2
  • The TTM is -103.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-103.4%TTM-103.4%0.0%
TTM-103.4%YOY-139.1%+35.7%
TTM-103.4%5Y-116.0%+12.6%
5Y-116.0%10Y-81.1%-34.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-103.4%-31.8%-71.6%
TTM-103.4%-14.7%-88.7%
YOY-139.1%-12.3%-126.8%
5Y-116.0%-20.5%-95.5%
10Y-81.1%-25.1%-56.0%
1.2.2. Operating Ratio

Measures how efficient Control Bionics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 2.16 means that the operating costs are $2.16 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Control Bionics Ltd:

  • The MRQ is 2.157. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.157. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.157TTM2.1570.000
TTM2.157YOY2.508-0.352
TTM2.1575Y1.461+0.696
5Y1.46110Y0.956+0.505
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1571.454+0.703
TTM2.1571.478+0.679
YOY2.5081.450+1.058
5Y1.4611.484-0.023
10Y0.9561.380-0.424
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Control Bionics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Control Bionics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 2.52 means the company has $2.52 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Control Bionics Ltd:

  • The MRQ is 2.524. The company is able to pay all its short-term debts. +1
  • The TTM is 2.524. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.524TTM2.5240.000
TTM2.524YOY6.325-3.801
TTM2.5245Y13.626-11.101
5Y13.62610Y16.781-3.155
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5242.883-0.359
TTM2.5242.860-0.336
YOY6.3253.719+2.606
5Y13.6263.643+9.983
10Y16.7813.554+13.227
1.3.2. Quick Ratio

Measures if Control Bionics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Control Bionics Ltd to the Medical Devices industry mean.
  • A Quick Ratio of 1.77 means the company can pay off $1.77 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Control Bionics Ltd:

  • The MRQ is 1.769. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.769. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.769TTM1.7690.000
TTM1.769YOY5.127-3.358
TTM1.7695Y12.995-11.225
5Y12.99510Y16.406-3.411
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7691.627+0.142
TTM1.7691.634+0.135
YOY5.1272.201+2.926
5Y12.9952.268+10.727
10Y16.4062.263+14.143
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Control Bionics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Control Bionics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Control Bionics Ltd to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.18 means that Control Bionics Ltd assets are financed with 17.8% credit (debt) and the remaining percentage (100% - 17.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Control Bionics Ltd:

  • The MRQ is 0.178. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.178. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.178TTM0.1780.000
TTM0.178YOY0.113+0.066
TTM0.1785Y0.089+0.089
5Y0.08910Y0.247-0.158
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1780.382-0.204
TTM0.1780.385-0.207
YOY0.1130.329-0.216
5Y0.0890.442-0.353
10Y0.2470.465-0.218
1.4.2. Debt to Equity Ratio

Measures if Control Bionics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Control Bionics Ltd to the Medical Devices industry mean.
  • A Debt to Equity ratio of 21.7% means that company has $0.22 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Control Bionics Ltd:

  • The MRQ is 0.217. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.217. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.217TTM0.2170.000
TTM0.217YOY0.127+0.090
TTM0.2175Y0.101+0.115
5Y0.10110Y0.812-0.711
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2170.546-0.329
TTM0.2170.548-0.331
YOY0.1270.465-0.338
5Y0.1010.620-0.519
10Y0.8120.699+0.113
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Control Bionics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Control Bionics Ltd generates.

  • Above 15 is considered overpriced but always compare Control Bionics Ltd to the Medical Devices industry mean.
  • A PE ratio of -4.51 means the investor is paying $-4.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Control Bionics Ltd:

  • The EOD is -1.303. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.510. Based on the earnings, the company is expensive. -2
  • The TTM is -4.510. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.303MRQ-4.510+3.207
MRQ-4.510TTM-4.5100.000
TTM-4.510YOY-10.723+6.213
TTM-4.5105Y-11.197+6.687
5Y-11.19710Y-6.998-4.199
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.303-1.201-0.102
MRQ-4.510-1.609-2.901
TTM-4.510-2.182-2.328
YOY-10.723-2.571-8.152
5Y-11.197-2.051-9.146
10Y-6.998-1.851-5.147
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Control Bionics Ltd:

  • The EOD is -16.041. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -55.509. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -55.509. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.041MRQ-55.509+39.468
MRQ-55.509TTM-55.5090.000
TTM-55.509YOY-11.378-44.131
TTM-55.5095Y-20.534-34.975
5Y-20.53410Y-12.834-7.700
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-16.041-1.924-14.117
MRQ-55.509-2.404-53.105
TTM-55.509-3.958-51.551
YOY-11.378-6.019-5.359
5Y-20.534-5.249-15.285
10Y-12.834-5.844-6.990
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Control Bionics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 3.55 means the investor is paying $3.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Control Bionics Ltd:

  • The EOD is 1.027. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.553. Based on the equity, the company is fair priced.
  • The TTM is 3.553. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.027MRQ3.553-2.526
MRQ3.553TTM3.5530.000
TTM3.553YOY5.487-1.933
TTM3.5535Y3.494+0.059
5Y3.49410Y2.184+1.310
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.0272.098-1.071
MRQ3.5532.381+1.172
TTM3.5532.570+0.983
YOY5.4873.322+2.165
5Y3.4943.911-0.417
10Y2.1844.258-2.074
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Control Bionics Ltd.

3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Control Bionics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.028-0.0280%-0.031+10%0.001-2359%0.005-635%
Book Value Per Share--0.0420.0420%0.070-40%0.072-42%0.355-88%
Current Ratio--2.5242.5240%6.325-60%13.626-81%16.781-85%
Debt To Asset Ratio--0.1780.1780%0.113+58%0.089+101%0.247-28%
Debt To Equity Ratio--0.2170.2170%0.127+71%0.101+114%0.812-73%
Dividend Per Share----0%-0%-0%0.010-100%
Eps---0.033-0.0330%-0.036+8%-0.021-35%0.029-215%
Free Cash Flow Per Share---0.003-0.0030%-0.034+1157%-0.016+485%-0.014+430%
Free Cash Flow To Equity Per Share--0.0010.0010%-0.034+2445%0.006-74%0.088-98%
Gross Profit Margin--1.1091.1090%1.116-1%1.066+4%1.041+7%
Intrinsic Value_10Y_max---0.072--------
Intrinsic Value_10Y_min---0.125--------
Intrinsic Value_1Y_max---0.014--------
Intrinsic Value_1Y_min---0.018--------
Intrinsic Value_3Y_max---0.037--------
Intrinsic Value_3Y_min---0.050--------
Intrinsic Value_5Y_max---0.053--------
Intrinsic Value_5Y_min---0.077--------
Market Cap7339326.000-246%25397481.60025397481.6000%65422410.600-61%47104818.360-46%29440511.475-14%
Net Profit Margin---1.036-1.0360%-1.395+35%-1.189+15%-0.850-18%
Operating Margin---1.034-1.0340%-1.391+35%-1.160+12%-0.811-22%
Operating Ratio--2.1572.1570%2.508-14%1.461+48%0.956+126%
Pb Ratio1.027-246%3.5533.5530%5.487-35%3.494+2%2.184+63%
Pe Ratio-1.303+71%-4.510-4.5100%-10.723+138%-11.197+148%-6.998+55%
Price Per Share0.043-246%0.1490.1490%0.383-61%0.276-46%0.172-14%
Price To Free Cash Flow Ratio-16.041+71%-55.509-55.5090%-11.378-80%-20.534-63%-12.834-77%
Price To Total Gains Ratio-1.537+71%-5.318-5.3180%-12.487+135%-22.213+318%-22.213+318%
Quick Ratio--1.7691.7690%5.127-65%12.995-86%16.406-89%
Return On Assets---0.648-0.6480%-0.455-30%-0.347-46%-0.227-65%
Return On Equity---0.788-0.7880%-0.512-35%-0.395-50%-0.231-71%
Total Gains Per Share---0.028-0.0280%-0.031+10%0.001-2359%0.015-283%
Usd Book Value--4674565.0624674565.0620%7798121.382-40%8032915.099-42%45274132.962-90%
Usd Book Value Change Per Share---0.018-0.0180%-0.020+10%0.001-2359%0.003-635%
Usd Book Value Per Share--0.0270.0270%0.046-40%0.047-42%0.232-88%
Usd Dividend Per Share----0%-0%-0%0.007-100%
Usd Eps---0.022-0.0220%-0.023+8%-0.014-35%0.019-215%
Usd Free Cash Flow---299231.814-299231.8140%-3760501.962+1157%-1751605.192+485%-1648705.715+451%
Usd Free Cash Flow Per Share---0.002-0.0020%-0.022+1157%-0.010+485%-0.009+430%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%-0.022+2445%0.004-74%0.058-98%
Usd Market Cap4799919.204-246%16609952.96616609952.9660%42786256.532-61%30806551.207-46%19254094.505-14%
Usd Price Per Share0.028-246%0.0970.0970%0.251-61%0.180-46%0.113-14%
Usd Profit---3682766.214-3682766.2140%-3996012.594+9%-2467683.002-33%3710833.769-199%
Usd Revenue--3554614.9143554614.9140%2864663.880+24%2347414.757+51%48302152.308-93%
Usd Total Gains Per Share---0.018-0.0180%-0.020+10%0.001-2359%0.010-283%
 EOD+3 -5MRQTTM+0 -0YOY+20 -145Y+10 -2410Y+9 -27

4.2. Fundamental Score

Let's check the fundamental score of Control Bionics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.303
Price to Book Ratio (EOD)Between0-11.027
Net Profit Margin (MRQ)Greater than0-1.036
Operating Margin (MRQ)Greater than0-1.034
Quick Ratio (MRQ)Greater than11.769
Current Ratio (MRQ)Greater than12.524
Debt to Asset Ratio (MRQ)Less than10.178
Debt to Equity Ratio (MRQ)Less than10.217
Return on Equity (MRQ)Greater than0.15-0.788
Return on Assets (MRQ)Greater than0.05-0.648
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Control Bionics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.652
Ma 20Greater thanMa 500.047
Ma 50Greater thanMa 1000.045
Ma 100Greater thanMa 2000.048
OpenGreater thanClose0.043
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets8,696
Total Liabilities1,549
Total Stockholder Equity7,148
 As reported
Total Liabilities 1,549
Total Stockholder Equity+ 7,148
Total Assets = 8,696

Assets

Total Assets8,696
Total Current Assets3,869
Long-term Assets4,827
Total Current Assets
Cash And Cash Equivalents 936
Net Receivables 1,777
Inventory 802
Other Current Assets 201
Total Current Assets  (as reported)3,869
Total Current Assets  (calculated)3,715
+/- 154
Long-term Assets
Property Plant Equipment 720
Intangible Assets 4,107
Long-term Assets  (as reported)4,827
Long-term Assets  (calculated)4,827
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,533
Long-term Liabilities16
Total Stockholder Equity7,148
Total Current Liabilities
Short-term Debt 129
Accounts payable 517
Other Current Liabilities 887
Total Current Liabilities  (as reported)1,533
Total Current Liabilities  (calculated)1,533
+/-0
Long-term Liabilities
Other Liabilities 16
Long-term Liabilities  (as reported)16
Long-term Liabilities  (calculated)16
+/-0
Total Stockholder Equity
Common Stock30,242
Retained Earnings -23,365
Accumulated Other Comprehensive Income 271
Total Stockholder Equity (as reported)7,148
Total Stockholder Equity (calculated)7,148
+/-0
Other
Capital Stock30,242
Cash and Short Term Investments 936
Common Stock Shares Outstanding 90,235
Liabilities and Stockholders Equity 8,696
Net Debt -807
Net Invested Capital 7,148
Net Tangible Assets 3,041
Net Working Capital 2,336
Property Plant and Equipment Gross 1,770
Short Long Term Debt Total 129



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
622,700
743,953
1,203,929
6,306
5,429
20,513
18,353
13,436
8,696
8,69613,43618,35320,5135,4296,3061,203,929743,953622,700
   > Total Current Assets 
0
0
759,731
2,183
1,269
16,092
13,721
8,609
3,869
3,8698,60913,72116,0921,2692,183759,73100
       Cash And Cash Equivalents 
225,170
296,012
403,894
1,839
799
15,596
12,331
5,214
936
9365,21412,33115,5967991,839403,894296,012225,170
       Short-term Investments 
0
0
7,613
0
0
0
0
0
0
0000007,61300
       Net Receivables 
105,748
126,937
348,224
256
289
317
1,121
1,765
1,777
1,7771,7651,121317289256348,224126,937105,748
       Other Current Assets 
0
0
0
90
115
120
110
707
201
20170711012011590000
   > Long-term Assets 
0
0
226,167
0
0
4,421
4,632
4,827
4,827
4,8274,8274,6324,42100226,16700
       Property Plant Equipment 
0
0
0
10
31
288
534
734
720
7207345342883110000
       Goodwill 
36,554
53,372
154,953
0
0
0
0
0
0
000000154,95353,37236,554
       Intangible Assets 
7,518
13,311
59,501
4,081
4,080
4,085
4,079
4,072
4,107
4,1074,0724,0794,0854,0804,08159,50113,3117,518
       Long-term Assets Other 
0
0
-226,167
0
0
48
19
21
0
021194800-226,16700
> Total Liabilities 
463,798
550,265
911,309
216
376
387
1,190
1,512
1,549
1,5491,5121,190387376216911,309550,265463,798
   > Total Current Liabilities 
0
0
13,565
216
376
364
1,173
1,361
1,533
1,5331,3611,17336437621613,56500
       Short-term Debt 
0
0
7,613
0
0
37
15
160
129
1291601537007,61300
       Short Long Term Debt 
0
0
0
0
0
0
0
48
0
0480000000
       Accounts payable 
9,981
51,431
5,952
122
254
191
460
429
517
5174294601912541225,95251,4319,981
       Other Current Liabilities 
0
0
0
18
5
1
699
772
887
8877726991518000
   > Long-term Liabilities 
67,975
72,891
53,930
0
0
23
17
151
16
1615117230053,93072,89167,975
       Long term Debt Total 
0
0
0
0
0
245
0
125
0
0125024500000
       Other Liabilities 
0
0
0
0
0
13
17
27
16
1627171300000
> Total Stockholder Equity
158,902
193,688
292,620
6,090
5,053
20,126
17,163
11,924
7,148
7,14811,92417,16320,1265,0536,090292,620193,688158,902
   Common Stock
112,006
110,070
168,602
10,544
11,477
27,637
28,175
29,267
30,242
30,24229,26728,17527,63711,47710,544168,602110,070112,006
   Retained Earnings 
47,340
84,561
97,441
-5,145
-7,077
-8,257
-11,633
-17,734
-23,365
-23,365-17,734-11,633-8,257-7,077-5,14597,44184,56147,340
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
-943
26,577
692
653
745
621
391
90
9039162174565369226,577-9430



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue5,435
Cost of Revenue-1,931
Gross Profit3,5043,504
 
Operating Income (+$)
Gross Profit3,504
Operating Expense-9,790
Operating Income-5,619-6,286
 
Operating Expense (+$)
Research Development231
Selling General Administrative5,292
Selling And Marketing Expenses617
Operating Expense9,7906,140
 
Net Interest Income (+$)
Interest Income24
Interest Expense-12
Other Finance Cost-13
Net Interest Income-1
 
Pretax Income (+$)
Operating Income-5,619
Net Interest Income-1
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,631-6,275
EBIT - interestExpense = -5,631
-4,963
-5,619
Interest Expense12
Earnings Before Interest and Taxes (EBIT)-5,619-5,619
Earnings Before Interest and Taxes (EBITDA)-5,138
 
After tax Income (+$)
Income Before Tax-5,631
Tax Provision-0
Net Income From Continuing Ops-5,631-5,631
Net Income-5,631
Net Income Applicable To Common Shares-5,631
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses11,721
Total Other Income/Expenses Net6561
 

Technical Analysis of Control Bionics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Control Bionics Ltd. The general trend of Control Bionics Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Control Bionics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Control Bionics Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.048 < 0.048 < 0.05.

The bearish price targets are: 0.042 > 0.042 > 0.041.

Tweet this
Control Bionics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Control Bionics Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Control Bionics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Control Bionics Ltd. The current macd is -0.00022656.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Control Bionics Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Control Bionics Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Control Bionics Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Control Bionics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartControl Bionics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Control Bionics Ltd. The current adx is 15.67.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Control Bionics Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Control Bionics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Control Bionics Ltd. The current sar is 0.05015805.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Control Bionics Ltd Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Control Bionics Ltd. The current rsi is 41.65. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Control Bionics Ltd Daily Relative Strength Index (RSI) ChartControl Bionics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Control Bionics Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Control Bionics Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Control Bionics Ltd Daily Stochastic Oscillator ChartControl Bionics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Control Bionics Ltd. The current cci is -147.40061162.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Control Bionics Ltd Daily Commodity Channel Index (CCI) ChartControl Bionics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Control Bionics Ltd. The current cmo is -29.71809916.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Control Bionics Ltd Daily Chande Momentum Oscillator (CMO) ChartControl Bionics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Control Bionics Ltd. The current willr is -87.5.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Control Bionics Ltd Daily Williams %R ChartControl Bionics Ltd Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Control Bionics Ltd.

Control Bionics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Control Bionics Ltd. The current atr is 0.0017405.

Control Bionics Ltd Daily Average True Range (ATR) ChartControl Bionics Ltd Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Control Bionics Ltd. The current obv is 1,736,954.

Control Bionics Ltd Daily On-Balance Volume (OBV) ChartControl Bionics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Control Bionics Ltd. The current mfi is 82.60.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Control Bionics Ltd Daily Money Flow Index (MFI) ChartControl Bionics Ltd Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Control Bionics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-10-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-10-16STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-10-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-10-25STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Control Bionics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Control Bionics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.652
Ma 20Greater thanMa 500.047
Ma 50Greater thanMa 1000.045
Ma 100Greater thanMa 2000.048
OpenGreater thanClose0.043
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Control Bionics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Control Bionics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Control Bionics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Control Bionics Ltd

I send you an email if I find something interesting about Control Bionics Ltd.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about Control Bionics Ltd.

Receive notifications about Control Bionics Ltd in your mailbox!